KLRK1 and neoplasm: In human differentiated glioblastoma cells and cancer initiation cells, and subcutaneous tumor models showed cellular eradication after CAR T-cell therapy; however, NKG2D-ligands on normal tissues are expressed under distress, which may result in human toxicity (Yang D. et al., 2019).